What began in 1864 as a small glass factory in Gerresheim near Düsseldorf has developed into a leading global partner to the pharmaceutical and healthcare industry. This path has been characterized by innovation, change and the ability to constantly face new challenges. Join us on a journey through the milestones of our history - from the beginnings of glass production to today's specialization in innovative solutions for drug packaging and drug delivery devices.
From founding to shareholding company
1864 The company was founded by Ferdinand Heye
1864 - 1888
1886 The biggest bottle maker in the world
1888 Transformation into a joint stock company
Change
1972 Renaming of the company. From this year onwards the company is called Gerresheimer Glas AG
1972 - 1987
1985 Relocation of headquarters
1987 Development of tubing-based pharmaceutical glass product business
A historical turning point
1999 Sale of the glassworks in Gerresheim
1999
1999 New global organization structure: strategic reorientation to focus on pharmaceutical, laboratory, cosmetic and small glass products
New global organizational structure & IPO
2007 New global organization structure
2007
2007 Gerresheimer AG is stock exchange listed
New strategic positioning of the divisions
2013 Divisional reorganization: Plastics & Devices, Primary Packaging Glass and Life Science Research
2013 - 2016
2015 Acquisition of Centor
2015 Sale of tubing operations to Corning
2016 Sale of Life Science Research operations
Current events
2018 Gerresheimer acquires Swiss technology company Sensile Medical
2018 - 2024
2018 New CEO and Management Board of Gerresheimer AG: Dietmar Siemssen CEO, Dr. Bernd Metzner CFO, Dr. Lukas Burkhardt
2019 Opening Plastic Packaging Plant in Changzhou, China
2019 Focus on Innovation: new setup with new division Advanced Technology in addition to Primary Packaging Glass and Plastics & Devices
2019 Opening Glass Innovation and Technology Center Vineland/NJ, USA
2020 Opening Medical Device Plant Skopje, North Macedonia
2021 New Corporate design
2024 Acquisition of Bormioli Pharma Group
